(Q42991657)

12 November 2017

Role of the N-linked glycans of the prM and E envelope proteins in tick-borne encephalitis virus particle secretion (English)

1 reference

12 November 2017

tick-borne encephalitis

1 reference

tick-borne encephalitis virus

inferred from title

object named as

tick-borne encephalitis virus

1 reference

5

Tetsuya Mizutani

1 reference

12 November 2017

6

Hiroaki Kariwa

1 reference

12 November 2017

7

Ikuo Takashima

1 reference

12 November 2017

3

Mayumi Obara

1 reference

12 November 2017

2

Kentarou Yoshii

1 reference

12 November 2017

4

Tomotaka Ueki

1 reference

12 November 2017

Akiko Goto

1

1 reference

PubMed ID

15811651

12 November 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

12 November 2017

1 reference

12 November 2017

23

1 reference

12 November 2017

23

1 reference

12 November 2017

3043-3052

1 reference

Flavivirus genome organization, expression, and replication

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Pathogenicity of tick-borne encephalitis virus isolated in Hokkaido, Japan in mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

7 January 2021

Tick‐Borne Encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Glycosylation inhibitors for N-linked glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

A BHK-21 cell culture-adapted tick-borne encephalitis virus mutant is attenuated for neuroinvasiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Epitope model of tick-borne encephalitis virus envelope glycoprotein E: analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Lectins and traffic in the secretory pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Structures and mechanisms in flavivirus fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Role of vaccinia virus A20R protein in DNA replication: construction and characterization of temperature-sensitive mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Characterization of monoclonal antibodies against Hokkaido strain tick-borne encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Enzyme-linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic domain of at least 350 kDa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Intracellular Assembly and Secretion of Recombinant Subviral Particles from Tick-Borne Encephalitis Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Assembly and Maturation of the Flavivirus Kunjin Virus Appear To Occur in the Rough Endoplasmic Reticulum and along the Secretory Pathway, Respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Studies on the glycosylation of flavivirus E proteins and the role of carbohydrate in antigenic structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Antiviral effects of an iminosugar derivative on flavivirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Fbs2 is a new member of the E3 ubiquitin ligase family that recognizes sugar chains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Enzyme-linked immunosorbent assay using recombinant antigens expressed in mammalian cells for serodiagnosis of tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Structures of immature flavivirus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

7 January 2021

inferred from DOI database lookup

Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

7 January 2021

inferred from DOI database lookup

A case of tick-borne encephalitis in Japan and isolation of the the virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.068

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2004.11.068

1 reference

12 November 2017

1 reference

PubMed ID

15811651